The human T-cell leukemia virus type 1 (HTLV-1) Tax oncoprotein repressed the transcriptional activity of wildtype p53 through its N-terminal trans-activation domain. Although Tax did not directly bind to p53, this repression required the activation of CREB pathway by Tax. In contrast to a recent report by Pise-Masison et al. (1998a,b) we found that the phosphorylation of p53 on Ser 15 is not a major cause of the Tax-mediated inactivation of p53. However, Tax with a mutation in the coactivator CBP-binding site (K88A), which activates NF-kB but not the CREB pathway, could not repress the p53 trans-activation function. Moreover, Tax inhibited p53 binding to CBP in vitro and inhibited synergistic activation of transcription by CBP and p53. Thus, Tax is likely to compete with p53 in binding with CBP, thereby repressing its trans-activation function.
Introduction
Human T-cell leukemia virus type 1 (HTLV-1) is the etiological agent of adult T-cell leukemia (ATL) (for review, see Uchiyama, 1997) . Tax, a transcriptional trans-activator of HTLV-1, activates several cellular transcription factors, such as CREB and NF-kB (Smith and Greene 1990) . Activation of cellular genes is thought to be essential for Tax-mediated cell transformation. In this regard, it was previously demonstrated that the NF-kB but not the CREB pathway is essential for the Tax-mediated cellular transformation (Yamaoka et al., 1996) .
Tax is also involved in perturbation of cell cycle regulation by binding and inactivating the cyclindependent kinase (CDK) inhibitor p16
INK4A (Suzuki et al., 1996) , and by expressing high levels of another CDK inhibitor, p21
Waf1/Cip1/Sdi1 (Akagi et al., 1996; Cereseto et al., 1996) . Tax accelerates phase progression from G 1 to S in T-cells by indirectly regulating hyperphosphorylation of the retinoblastoma tumor suppressor gene product (pRb), and thus elevation of active E2F2 level, a member of the E2F transcription factor family (Neuveut et al., 1998) . Moreover, Tax targeted mitotic checkpoint protein, MAD1, thereby abrogating mitotic checkpoint (Jin et al., 1998) . Thus, Tax abrogates both G 1 /S and M checkpoints.
The tumor suppressor gene, p53, which plays important roles in cell cycle regulation and DNArepair, is mutated in various human tumors (Levine, 1997) . Many DNA viral oncoproteins including SV40 T antigen, human papillomavirus (HPV) E6, adenovirus E1B and adenovirus E4orf6 oncoprotein inhibit p53 function through direct binding (Bargonetti et al., 1992; Dobner et al., 1996; Schener et al., 1990; Segawa et al., 1992; Yew and Berk 1992; . Mutated p53 genes have been found in only quarter of ATL cases, while many transformed uninfected T-cell lines carry p53 mutations (Nagai et al., 1991; Yamato et al., 1993) . Previous studies have indicated stabilization of wild-type p53 and impairment of the trans-activation function of p53 in HTLV-1-transformed cell lines and Tax-immortalized T-cells (Akagi et al., 1997b; Cereseto et al., 1996; Mulloy et al., 1998; Pise-Masison et al., 1998a; Reid et al., 1993; Yamato et al., 1993) . The mechanism of inactivation of p53 by Tax, however, is not fully been understood. To address this issue, we investigated the biochemical properties of p53 in HTLV-1-transformed cell lines and Tax-expressing cells. In this study, we demonstrated that Tax does not directly bind p53 and that Tax represses the transcriptional activity of wild-type p53 through its N-terminal trans-activation domain. This repression requires the CREB but not NF-kB-activating domain of Tax. Inconsistent with a recent report by Pise-Masison et al. (1998b) , we found that the phosphorylation of p53 on Ser 15 is not a major cause of the Tax-mediated suppression of p53. Furthermore, we demonstrated that Tax competes with p53 in the binding with the coactivator CBP, thereby repressing p53 trans-activation function.
Results
Repression of p53 trans-activation function through the Tax-mediated activation of CREB pathway Previous studies showed that HTLV-1 Tax represses the trans-activation function of p53 (Akagi et al., 1997b; Cereseto et al., 1996; Pise-Masison et al., 1998a) . However, the mechanism of the Tax-mediated repression of p53 trans-activation function has not been fully elucidated. Tax mutants showing dierent responses to HTLV-1 LTR and the NF-kB-dependent promoter were examined for their abilities to inactivate p53. Saos2 cells were co-transfected with wild-type (wt) or mutant Tax expression plasmids (m137, m148, and m319) (Yamaoka et al., 1996) , p53-expression plasmid, and a luciferase reporter plasmid containing the consensus p53-responsive sequence (p53-RE-Luc) (Kiyono et al., 1994) . Wild-type Tax activated both the CREB and NF-kB pathways, while mutant m137 failed to activate either pathway. The mutant m148 activated the CREB but not the NF-kB pathway. Conversely, mutant m319 activated the NF-kB but not the CREB pathway. Consistent with the results of previous studies (Akagi et al., 1997b; Cereseto et al., 1996; Pise-Masison et al., 1998a) , wild-type Tax repressed the trans-activation function of p53 in Saos2 cells (Figure 1 ). Mutants m137 and m319 failed to repress p53 function. In contrast, mutant m148 repressed the p53 function to a similar extent as wildtype Tax. Thus, suppression of p53 seems to be the result of activation of the CREB pathway by Tax or through factors involved in activation of the CREB pathway by Tax.
Tax-mediated repression of the transcriptional activity of p53 through its N-terminal trans-activation domain To determine whether Tax repressed the p53 transactivation function through its N-terminal transactivation domain, we constructed fusion proteins of the Gal4-DNA-binding domain with the N-terminal sequences of p53 for further analysis. The DNAbinding domain of Gal4 was fused to the ®rst 52 amino acids of p53 (p53NS) containing the p53 transactivation subdomain 1 (Venot et al., 1999) , to the ®rst 61 amino acids (p53NM) containing subdomain 1 and part of subdomain 2, or to the ®rst 105 amino acids (p53NL) containing both trans-activation subdomains 1 and 2, and the proline-rich domain ( Figure  2a ). These Gal4-p53N fusion constructs were transfected into Saos2 cells along with Gal4-luciferase reporter, Gal4-Luc (Figure 2b ), and luciferase assay was performed. Although Gal4-p53NS weakly activated the Gal4-luciferase activity, Gal4-p53NM and Gal4-p53NL showed similar strong activation ( Figure  2c ), indicating that only the putative N-terminal transactivation domain of p53 does not have sucient transcriptional activity and the adjacent region (amino acid residues 52 ± 61) but not the proline-rich domain is also essential for the full trans-activation activity. Importantly, Tax repressed all these Gal4-p53N transactivation function (Figure 2c ), indicating that Tax represses the p53 trans-activation function through its N-terminal trans-activation domain.
Tax does not directly associate with p53
Most of DNA tumor viral oncoproteins bind to p53 and inactivate its function. Therefore, we performed co-immunoprecipitation experiments to examine whether Tax also binds directly to p53. Immunoprecipitation with anti-p53 or anti-Tax antibody of 35 Slabeled MT-2 cell lysates revealed that Tax does not co-immunoprecipitate with p53 ( Figure 3a, lanes 1 and  3) . A 68 kDa protein (Figure 3a , lane 3) immunoprecipitated with anti-Tax antibody was found only in MT-2 cells, and was previously identi®ed as the TaxEnv fusion protein (Takeuchi et al., 1985) . Similarly, immunoprecipitation with anti-p53 or anti-Tax antibody of 35 S-labeled Tax and p53 expressing COS7 cell lysates revealed that Tax does not co-immunoprecipitate with p53 ( Figure 3b , lanes 1 and 2), indicating that Tax does not directly bind to p53. In fact, we observed that Tax does not co-localize with p53 by indirect immuno¯uorescence study (data not shown). Thus, Figure 1 Repression of p53 trans-activation function through Tax-mediated activation of the CREB pathway. Using the FuGENE6 transfection reagent, Saos2 cells were cotransfected with 0.25 mg of reporter plasmid, p53-RE-Luc, 0.5 mg of pcDNA3 p53 and 0.5 mg of wild-type Tax (wt) or mutant Tax expression plasmids (m137, m148, and m319) and luciferase assays were performed 24 h later Figure 2 Tax-mediated repression of p53 trans-activation function through its N-terminal trans-activation domain. (a) Schematic representation of the pGal4-p53NS (amino acid residues 1 ± 52), pGal4-p53NM (1 ± 61), pGal4-p53NL (1 ± 105) and pGal4 DNA-binding domain expression plasmids. (b) Using FuGENE6, Saos2 cells were cotransfected with 0.25 mg of reporter plasmid, pGal4-Luc, 1 mg of wild-type Tax expression plasmid, and 0.5 mg of pGal4-p53NS, pGal4-p53NM, or pGal4-p53NL, and luciferase assays were performed 24 h later Tax might inactivate p53 by an indirect mechanism. Moreover, Tax did not aect the nuclear localization nor the DNA-binding activity of p53 (data not shown). These observations were in contrast to many DNA viral oncoproteins.
Phosphorylation of p53 on Ser 15 is not a major cause of the Tax-mediated inactivation of p53
It has been suggested that p53 activity is regulated by phosphorylation of its N-terminal region such as serine 15 after DNA damage (Shieh et al., 1997; Siliciano et al., 1997) . We observed that p53 in MT-2 cells under normal culture conditions is unphosphorylated on Ser 15, but induction of phosphorylation of p53 on Ser 15 occurred following g-ray irradiation (10 Gy) ( Figure  4b ). Such induction of phosphorylation on p53 was also observed in MCF7 cells (Figure 4a ). Moreover, we also observed the phosphorylation of p53 on Ser 15, Ser 33 and Ser 37 in MT-2 cells after X-ray irradiation (7 Gy) ( Figure 4c ). To determine whether phosphorylation of Ser 15 is involved in Tax-mediated repression of p53 trans-activation function, mutant p53 expression plasmids (S15A and S15E), which have a single point mutation on Ser 15 to alanine or glutamic acid, respectively, were cotransfected with p53-reporter plasmid and luciferase assay was then performed. Transfection of these mutants resulted in activation of p53-dependent gene expression to the same level as in wild-type p53 in Saos2 cells, indicating that the phosphorylation of Ser 15 is not important for its transcriptional activation (Figure 5a ). However, cotransfection of these mutants with Tax expression plasmid resulted in repression of their activity to almost the same level as Tax suppressed wild-type p53 in Saos2 cells ( Figure 5a ). Moreover, the activities of both mutants were also trans-suppressed in MT-2 cells ( Figure 5b ). These results were in contrast to a recent report (Pise-Masison et al., 1998b) , and suggested that phosphorylation of Ser 15 is not involved in Tax-mediated suppression of p53.
Tax and p53 mutually repress each others transcription
It has been suggested that coactivator CBP functions as a signal integrator among various transcription factors (Shikama et al., 1997) . CBP directly binds to p53 and activates its trans-activation function by acetylation (Avantaggiati et al., 1997; Lill et al., 1997; Liu et al., 1999; Sakaguchi et al., 1998; Scolnick et al., 1997) . Conversely, CBP also binds to Tax and activates the HTLV-1 LTR promoter activity (Harrod et al., 1998; Kwok et al., 1996) . In this study, we demonstrated that Tax represses the p53 trans-activation function through involvement of the CREB pathway of Tax (Figure 1) . CBP was originally identi®ed as a CREB-binding protein. Therefore, if CBP functions as a signal integrator between Tax and p53, there might be mutual transcriptional interference between these proteins. To determine whether Tax and p53 mutually repress each others transcription, p53 reporter plasmid or HTLV-1 LTR reporter plasmid was cotransfected with p53 and Tax expression plasmid. As expected, cotransfection of Tax expression plasmid to p53 expression plasmid resulted in repression of the p53 trans-activation function in a dose-dependent manner in Saos2 cells ( Figure 6 ). Conversely, cotransfection of a 100-fold molar excess of p53 expression plasmid relative to the Tax expression plasmid resulted in marked repression of the Tax-mediated LTR promoter activity ( Figure 6 ). Thus, p53-dependent gene expression was repressed by Tax, and Tax-mediated trans-activation function was repressed by excess amount of p53.
Competition between Tax and p53 in binding with CBP coactivator
Recently, the CBP-binding domain of Tax was identi®ed around amino acid residues 81 ± 95, and the Tax-binding domain of CBP was shown to overlap with the CREB-binding domain (Harrod et al., 1998) . To determine whether CBP is involved in the Taxmediated repression of p53 function, we used a mutant Tax with a mutation in the CBP-binding site (K88A). This mutant Tax, K88A, has lost its CBP-binding activity (Harrod et al., 1998) . Although wild-type Tax activated both HTLV-1 LTR-and NF-kB-dependent gene expression, K88A activated NF-kB but not LTR promoter activity (Figure 7a, b) , suggesting that CBP is essential for the CREB pathway in the LTR promoter activation but not Tax-mediated NF-kB pathway. Using this mutant Tax, we analysed the eects on p53 trans-activation function. As expected, K88A did not eectively repress the p53 trans-activation function (Figure 7c) . Similarly, K88A could not repress the trans-activation function of Gal4-p53NM (Figure 7d ). These results suggested that CBP is involved in Taxmediated repression of p53 trans-activation function.
To con®rm this hypothesis, we examined whether ectopically expressed CBP rescues the Tax-mediated repression of p53 function. Contransfection of CBP with p53 expression plasmid resulted in synergistic activation of p53 trans-activation function in Saos2 cells (Figure 8a) . Importantly, CBP partly rescued the Tax-mediated repression of p53 function (Figure 8a) . We also performed similar assay in MCF7 cells, which have endogenous wild-type p53. In fact, ectopically expressed MDM2 signi®cantly repressed the p53-dependent gene expression in these cells (Figure 8b ). Although Tax repressed the endogenous p53 transactivation function, coexpression of CBP rescued this repression (Figure 8b ), suggesting that CBP is involved in the Tax-mediated repression of p53 trans-activation function. Furthermore, we performed GST pull-down assay to directly con®rm whether Tax inhibits p53 binding to CBP in vitro. In vitro translated ( 35 S-labeled) p53 and/or Tax proteins were incubated with GST alone (lane 1) or GST-C/H1-KIX (aa 362 ± 682) bound glutathione-Sepharose resin (lanes 2 ± 4). We observed that either p53 or Tax protein binds to GST-C/H1-KIX, respectively ( Figure 9 , lanes 2 ± 3). However, Tax inhibited p53 binding to GST-C/H1-KIX in the presence of both proteins (Figure 9 , lane 4), indicating that Tax inhibits p53 binding to CBP in vitro. Thus, Tax might compete with p53 in binding with CBP, thereby repressing its trans-activation function.
Discussion
In this study, we demonstrated that Tax represses the trans-activation function of p53 through competition between p53 and Tax in binding with CBP. This is a novel strategy that inactivates p53 by a viral oncoprotein, Tax, because most of DNA viral oncoproteins inactivate p53 through direct binding. CBP binds to the N-terminal trans-activation domain, acetylates the C-terminal domain of p53 and activates its transcriptional activity (Avantaggiati et al., 1997; Lill et al., 1997; Liu et al., 1999; Sakaguchi et al., 1998; Scolnick et al., 1997) . Conversely, CBP also binds Cells were incubated for 0.5 h after g-irradiation (10 Gy), and then aliquots of 100 mg of cell extracts used for immunoblotting analysis with anti-p53 antibody (DO-1) or polyclonal antibody speci®c for phosphorylated Ser 15. (c) Phosphorylation of p53 on Ser 15, Ser 33, and Ser 37 in MT-2 cells after X-ray irradiation. Cells were incubated for 1 h after X-ray irradiation (7 Gy), and then immunoblotting analysis was performed using anti-p53 antibody (PAb 1801) or antibody speci®c for phospho-Ser 15, Ser 33 or Ser 37 to Tax and activates the CREB pathway in HTLV-1 LTR (Harrod et al., 1998; Kwok et al., 1996) . Moreover, Tax and p53 mutually repressed each others transcription (Figure 6 ), suggesting that CBP functions as a signal integrator between Tax and p53.
Recently, the CBP-binding domain of Tax was identi®ed around amino acid residues 81 ± 95, and the Tax-binding domain of CBP was shown to overlap with the CREB-binding domain (Harrod et al., 1998) . Interestingly, the mutant Tax, K88A, activated the NF-kB but not CREB pathway, and showed loss of the CBP-binding activity (Figure 7a , b), suggesting that CBP is essential for the Taxmediated activation of the CREB but not the NF-kB pathway. As expected, K88A could not repress the p53 trans-activation function (Figure 7c ). Conversely, ectopically expressed CBP partly rescued this repression (Figure 8) . Moreover, Tax inhibited p53 binding to CBP in vitro (Figure 9b) . Thus, CBP might be involved in the Tax-mediated repression of p53 transactivation function. Using the SuperFect transfection reagent, MT-2 cells were cotransfected with 0.5 mg of p53-RE-Luc, 2 mg of pcDNA3 p53, pcDNA3 p53 (S15A) or pcDNA3 p53 (S15E), and luciferase assays were performed 24 h later It has been suggested that p53 activity is regulated by phosphorylation of p53 on Ser 15 after DNA damage (Shieh et al., 1997; Siliciano et al., 1997) . In this regard, Pise-Masison et al. (1998b) recently demonstrated the constitutive phosphorylation of p53 on Ser 15 in HTLV-1-infected cell lines, and concluded that this phosphorylation is involved in Tax-mediated inactivation of p53. We observed the DNA damagedependent phosphorylation of p53 on Ser 15 in the HTLV-1-infected cell line MT-2 using the antibody which speci®cally recognizes p53 phosphorylated at Ser 15 (Shieh et al., 1997; Siliciano et al., 1997) (Figure 4) , and the stronger DNA-binding activity of p53 after DNA damage (data not shown), suggesting that the sensor of DNA damage is normal in the cell line. Moreover, using p53 mutants on Ser 15 (S15A and S15E), we have shown that Tax repressed activities of these mutants as well as wild-type p53 ( Figure 5 ). Thus, we concluded that the phosphorylation of p53 on Ser 15 is not important for Tax-mediated repression of p53 trans-activation function. The reasons for the discrepancies between our results and those of PiseMasison et al. (1998b) should be clari®ed, but dierences in the speci®city of the antibodies recognizing phosphorylated serine 15 of p53 may have been responsible. Our antibody speci®cally recognized the phosphorylated form but not unphosphorylated p53. However, from the fact of the presence of the faint bands detected by the antibodies speci®c to p53 phosphorylated at Ser 15 or at Ser 37 in MT-2 cells (Figure 4 ) and slight dierence of Tax mediated repression of p53 mutants, S15A and S15E, ( Figure  5 ), it may not be able to exclude the possibility of the presence of dierent pathway of repression of p53 by Tax from that described in this paper. Consistent with the previous study (Fuchs et al., 1995) , we also demonstrated that phosphorylation of Ser 15 is not important for its transcriptional activation, since transfection of these mutants resulted in marked activation of p53-dependent gene expression as well as wild-type p53 in Saos2 cells (Figure 5a) . Similarly, we found that a single point mutation at other putative phosphorylation sites of the N-terminal region of p53, including Ser 6, 9, 20, 33 and 37, is not important for its transcriptional activation or the repression of p53 function by Tax (data not shown). We also demonstrated that only the putative N-terminal transactivation domain (1 ± 52 amino acid residues) of p53 does not have high transcriptional activity. However, the N-terminal region including the adjacent region (amino acid residues 52 ± 61) but not the proline-rich domain was required for higher trans-activation ( Figure 2) . As previously described, the trans-activation domain of p53 can be divided into two subdomains, amino acids 1 ± 40 (subdomain 1) and 43 ± 73 (subdomain 2) (Chang et al., 1995; Venot et al. 1999) . However, we showed that amino acid residues 62 ± 73 (Chen et al., 1996) and/or 1 or 5 mg of pCMV CBP and luciferase assays were performed 24 h later 4) . The bound proteins were resolved by electrophoresis in a 10% SDSpolyacrylamide gel and detected by autoradiography in subdomain 2 and proline-rich domain are dispensable for the p53 trans-activation function (Figure 2c ).
Previous studies demonstrated that Tax plays important roles in cell transformation, or clonal expansion of CD4+ T-cells (Akagi et al., 1997a; Yamaoka et al., 1996) . In addition to these functions with regard to its pathogenic roles in the development of ATL, Tax may play important roles in increasing genomic instability by suppressing p53 function through the mechanism described here or by inhibiting nucleotide excision repair (NER) through the activation of proliferating cell nuclear antigen (PCNA) gene expression (Kao and Marriott, 1999) . In fact, Tax was shown to increase mutation frequency (2.8-fold increase) of the cellular genome (Miyake et al., 1999) .
Recently, several proteins with sequence homology to p53, including p73 and p63/p51, have been identi®ed (Kaghad et al., 1997; Jost et al., 1997; Osada et al., 1998; Yang et al., 1998) . Some DNA viral oncoproteins, which are known to suppress p53 function, with the exception of the adenovirus E4orf6 oncoprotein, could not inactivate p73 (Higashino et al., 1998; Marin et al., 1998; Roth et al., 1998; Steegenga et al., 1999) . In contrast, we have found that Tax repressed the trans-activation function of p53-related proteins, p73 and p51/p63, through their N-terminal trans-activation domain as well as p53, suggesting that Tax inactivates p53-related proteins through a common mechanism, possibly by CBP sequestration (Kaida et al., unpublished manuscript) . During the review process of this paper, Orden et al. (1999a) and Suzuki et al. (1999) reported similar results that Tax and p53 compete for CBP. These reports may support our ®ndings. Furthermore, recent studies demonstrated that Tax represses other transcription functions, such as c-Jun or E-box, through CBP/p300 sequestration (Orden et al., 1999b; Suzuki et al., 1999) . Thus, these competition between Tax and cellular transcription factors may deregulate of cellular gene expression and be linked with cellular transformation.
Materials and methods

Cell culture
MT-2, the HTLV-1-infected T-cell line, and MCF7 cells were maintained in RPMI1640 medium supplemented with 10% heat-inactivated fetal calf serum (FCS) at 378C in a humidi®ed 5% CO 2 atmosphere. Saos2, COS7 and Rat1 cells were similarly maintained in Dulbecco's modi®ed Eagles medium supplemented with 10% FCS at 378C.
Plasmid construction
To construct pcDNA3 p53 (wt), a 1.8 kb BamHI fragment of pC53-SN3 (Baker et al., 1990) was subcloned into the same site of pcDNA3 vector (Invitrogen). Mutants pcDNA3 p53 (S15A and S15E) were generated by site-directed mutagenesis of wild-type p53 cDNA cloned into the pKF18k vector using a Mutan-Super Express Km kit (Takara). Mutant S15A had an amino acid substitution at codon 15 from Ser to Ala and mutant S15E had an amino acid substitution at codon 15 from Ser to Glu. Mutants were subcloned into the BamHI site of pcDNA3 vector. To construct pcDNA3 Tax (wt), the 1.33 kbp of BamHI ± SalI fragment of pLTEN wt (Akagi et al., 1997a) was subcloned into BamHI ± XhoI sites of pcDNA3. Mutant pcDNA3 Tax (K88A) was generated by site-direct mutagenesis of wild-type Tax cDNA in the same way as pcDNA3 p53 (S15A). Mutant K88A had an amino acid substitution at codon 88 from Lys to Ala. To construct pGal4-p53NS, a DNA fragment encoding amino acids 1 ± 52 of p53 was ampli®ed from pcDNA3p53 (wt) with two primers (5'-CGCGGATCCGCCATGGAGGAGCCGCAGT-CA-3' and 5'-CCCAAGCTTTTGTTCAATATCGTCCGG-GGA-3'). The resulting DNA fragment was subcloned into BamHI ± HindIII sites of the Gal4 DNA-binding domain expression plasmid, pM (Clontech). pGal4-p53NM (1 ± 61) and p53NL (1 ± 105) were generated in the same way as pGal4-p53NS except for the primers (pGal4-p53NM, 5'-CGCGGATCCGCCATGGAGGAGCCGCAGTCA-3' and 5'-CC CA AG CT T AT CT GGA CCT GGG TC TT C AGT-3'; pGal4-p53NL, 5'-CGCGGATCCGCCATGGAGGAGCCG-CAGTCA-3' and 5'-CCCAAGCTTGCCCTGGTAGGTTT-TCTGGGA-3'). To construct pGST-C/H1-KIX, a DNA fragment encoding amino acids 362 ± 682 of CBP was ampli®ed from pCMV CBP with two primers (5'-CGCGG-ATCCCATGCCCACAAATGT-3' and 5'-CCGCTCGAGT-GGCTGGTTACCCAG-3'). The resulting DNA fragment was subcloned into BamHI ± XhoI site of pGEX-6P-1 (Pharmacia).
Luciferase assay
Appropriate plasmids were transfected into Saos2, COS7 or Rat 1 cells using the FuGENE6 transfection reagent (Boehringer Mannheim) and luciferase assays were performed 24 h later. Similarly, plasmids were transfected into MT-2 or MCF7 cells using the SuperFect transfection reagent (Qiagen). All transfections were equalized for total DNA by addition of empty vector. Assays were performed with lysates obtained by three independent transfections.
Immunoblotting analysis
Cells were lysed in lysis buer containing 50 mM Tris-HCl (pH 8.0), 150 mM NaCl, 4 mM EDTA, 1% NP-40, 0.1% SDS, 1 mM DTT and 1 mM PMSF. The lysate was subjected to SDS ± PAGE, followed by immunoblotting analysis using anti-p53 (DO1, Calbiochem) or polyclonal antibody speci®c for phosphorylated p53 on Ser 15 (Shieh et al., 1997; Siliciano et al., 1997) Immunoprecipitation MT-2 or COS7 cells were metabolically labeled with Tran 35 S-label (ICN, 3.7 MBq/ml) at 378C for 6 h.
35
S-Labeled cells were lysed in lysis buer containing 10 mM Tris-HCl (pH 8.0), 150 mM NaCl, 1 mM EDTA, 1% NP-40, 1 mM DTT and 1 mM PMSF. The lysate was pre-cleared with 30 ml of protein-G-Sepharose (Pharmacia), and the supernatant was incubated with 2 mg of anti-p53 antibody (PAb 1801, Calbiochem), anti-Tax antibody (MI 73) (Yamaoka et al., 1996) or normal mouse IgG at 48C for 1 h. The precipitates were absorbed on 30 ml of protein-G-Sepharose resin, and the resin was washed four times with 600 ml of lysis buer. After elution by boiling the resin for 5 min in the 16Laemmli sample buer containing 50 mM Tris-HCl (pH 6.8), 2% SDS, 0.1% bromophenol blue (BPB), 10% glycerol and 5% 2-mercaptoethanol, the proteins were fractionated with a 7.5% SDS-polyacrylamide gel, and detected by autoradiography.
GST pull-down assay pGEX-6P-1 or pGST-C/H1-KIX were transformed into BL21 cells (Pharmacia). GST or GST-C/H1-KIX proteins were induced with 4 mM IPTG at 208C overnight and absorbed on the glutathione-Sepharose resin (Pharmacia) and then washed three times with 600 ml of PBST containing 0.5% Triton X-100 in PBS and twice with 600 ml of binding buer containing 10 mM Tris-HCl (pH 8.0), 150 mM NaCl, 1 mM EDTA, 0.1% NP-40, 1 mM DTT and 1 mM PMSF. To prepare p53 or Tax protein, 1 mg of pcDNA3 p53 or pcDNA3 Tax was added to 40 ml of TNT T7 quick coupled transcript/translation system (Promega) and incubated with L-[ 35 S]methionine (Amersham) at 308C for 2 h. The 35 Slabeled p53 and/or Tax proteins were incubated with GST or GST-C/H1-KIX protein bound glutathione-Sepaharose resin at 48C for 1 h and the resin was washed ®ve times with 600 ml of binding buer. The bound proteins were fractionated with a 10% SDS-polyacrylamide gel and detected by autoradiography.
